Precision medicine for diabetes management and primary cardiovascular prevention
Open Access
- 8 April 2019
- journal article
- letter
- Published by Wiley in Journal of Internal Medicine
- Vol. 286 (1) , 112-114
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Precision medicine in type 2 diabetesJournal of Internal Medicine, 2018
- Effects of Aspirin for Primary Prevention in Persons with Diabetes MellitusNew England Journal of Medicine, 2018
- Low-dose aspirin for primary cardiovascular prevention in diabetic patients: the issue to believe it or notAnnals of Translational Medicine, 2018
- Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?Diabetes & Metabolism, 2018
- 2016 European Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2016
- Diabetes and Antiplatelet Therapy in Acute Coronary SyndromeCirculation, 2011
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998